Erythrocyte and plasma magnesium in sickle-cell anaemia
- PMID: 2390957
Erythrocyte and plasma magnesium in sickle-cell anaemia
Abstract
Erythrocyte and plasma magnesium concentrations were measured in 168 subjects. Eighty three of the subjects were sickle-cell anaemia patients (sicklers) with haemoglobin genotype HbSS, and in the steady state; 30 were subjects who had the sickle-cell trait (HbAS), and 55 were subjects with the normal haemoglobin genotype HbAA. All the subjects were aged between 10 and 16 years. The sicklers had significantly lower erythrocyte (P less than 0.01) concentrations when compared with the normal subjects or subjects with the sickle-cell trait. Erythrocyte and plasma magnesium concentrations in subject with the sickle-cell trait were not significantly different from the corresponding values in the normal subjects. A significant negative correlation (r = -0.2661, P less than 0.02) was observed between erythrocyte magnesium and plasma magnesium in the sicklers only. However, magnesium concentrations in erythrocyte and plasma were not related to age, sex and physical stature in the three study groups. These results suggest that sickle-cell anaemia patients may be magnesium deficient.
Similar articles
-
Current observations on sickle cell genotype in Nigeria.East Afr Med J. 1993 Oct;70(10):646-9. East Afr Med J. 1993. PMID: 7514527
-
Plasma, erythrocyte and urinary selenium levels in sickle cell homozygotes and traits.Turk J Pediatr. 1993 Apr-Jun;35(2):105-9. Turk J Pediatr. 1993. PMID: 8249189
-
Rouleaux formation in sickle cell traits.J Trop Med Hyg. 1991 Feb;94(1):42-4. J Trop Med Hyg. 1991. PMID: 1995933
-
Optimal haematocrit in subjects with normal haemoglobin genotype (HbAA), sickle cell trait (HbAS), and homozygous sickle cell disease (HbSS).Clin Hemorheol Microcirc. 2011;47(4):253-60. doi: 10.3233/CH-2011-1387. Clin Hemorheol Microcirc. 2011. PMID: 21654054
-
Sickle cell trait and sickle cell anemia: a review.Mil Med. 1983 Sep;148(9):701-6. Mil Med. 1983. PMID: 6415531 Review. No abstract available.
Cited by
-
Magnesium for treating sickle cell disease.Cochrane Database Syst Rev. 2019 Sep 9;9(9):CD011358. doi: 10.1002/14651858.CD011358.pub3. Cochrane Database Syst Rev. 2019. PMID: 31498421 Free PMC article.
-
The association of bone mineral density and parathyroid hormone with serum magnesium in adult patients with sickle-cell anaemia.Arch Med Sci. 2012 May 9;8(2):270-6. doi: 10.5114/aoms.2012.28554. Arch Med Sci. 2012. PMID: 22662000 Free PMC article.
-
Total Serum Magnesium Levels and Calcium-To-Magnesium Ratio in Sickle Cell Disease.Medicina (Kaunas). 2019 Aug 29;55(9):547. doi: 10.3390/medicina55090547. Medicina (Kaunas). 2019. PMID: 31470666 Free PMC article.
-
Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease.J Clin Invest. 1997 Oct 1;100(7):1847-52. doi: 10.1172/JCI119713. J Clin Invest. 1997. PMID: 9312186 Free PMC article. Clinical Trial.
-
Magnesium for treating sickle cell disease.Cochrane Database Syst Rev. 2017 Apr 14;4(4):CD011358. doi: 10.1002/14651858.CD011358.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2019 Sep 09;9:CD011358. doi: 10.1002/14651858.CD011358.pub3. PMID: 28409830 Free PMC article. Updated.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical